(Q42063327)

15 October 2017

Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model (English)

1 reference

Soluble epoxide hydrolase

15 October 2017

0 references

1 reference

0 references

author

Bora Inceoglu

6

1 reference

15 October 2017

7

Oliver Fiehn

1 reference

15 October 2017

Arzu Ulu

1

1 reference

15 October 2017

Benjamin B Davis

2

1 reference

15 October 2017

Hsing-Ju Tsai

3

1 reference

15 October 2017

In-Hae Kim

4

1 reference

15 October 2017

Christophe Morisseau

5

1 reference

15 October 2017

Bruce D Hammock

8

1 reference

15 October 2017

Robert H Weiss

9

1 reference

15 October 2017

1 October 2008

1 reference

Journal of Cardiovascular Pharmacology

15 October 2017

1 reference

15 October 2017

52

1 reference

15 October 2017

4

1 reference

15 October 2017

314-323

1 reference

Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

The soluble epoxide hydrolase as a pharmaceutical target for hypertension

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Risk factors for atherosclerotic disease: present and future.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burst

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Review article: hyperlipidaemia and cardiovascular risk

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Soluble epoxide hydrolase is a therapeutic target for acute inflammation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Atherosclerosis: the new view

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Leukotoxin, 9,10-epoxy-12-octadecenoate causes pulmonary vasodilation in rats.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Quantitative assessment of atherosclerotic lesions in mice

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Vascular localization of soluble epoxide hydrolase in the human kidney

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637359

Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice

17 August 2018

1 reference

12 December 2020

Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s

1 reference

12 December 2020

Existence of leukotoxin 9,10-epoxy-12-octadecenoate in lung lavages from rats breathing pure oxygen and from patients with the adult respiratory distress syndrome

1 reference

12 December 2020

Cardiovascular effects of leukotoxin (9, 10-epoxy-12-octadecenoate) and free fatty acids in dogs

1 reference

12 December 2020

Leukotoxin, a linoleate epoxide: its implication in the late death of patients with extensive burns

1 reference

12 December 2020

The effect of adrenocorticotrophic hormone on water intake in mice

1 reference

12 December 2020

Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels

1 reference

12 December 2020

10.1097/FJC.0B013E318185FA3C

Identifiers

DOI

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

18791465

1 reference